Live
- NTR should be awarded Bharat Ratna, says CM
- Vizag mafia rules sand ramps in Srikakulam district
- Unselfishness is a Lie
- ICTPL welcomes maiden vessel MV KSL Fuyang
- BJP leaders mock Rahul's speech
- Analysing Happiness
- Two-day ToT organised for trainers
- Savarkar preferred Manusmriti to Constitution: Rahul
- Daily Horoscope for 15 December 2024: Embrace Today’s Insights of Your Zodiac Sign and Unlock Your Potential.
- Beyond The Flames
Just In
Turns out, male contraception can be there which can stop sperms without affecting hormones.
Washington D.C. (U.S.A.): Turns out, male contraception can be there which can stop sperms without affecting hormones.
According to a study published by the University of North Carolina Health Care, a compound called EP055 binds to sperm proteins to significantly slow the overall mobility of the sperm without affecting hormones, making EP055 a potential "male pill" without side effects.
"Simply put, the compound turns-off the sperm's ability to swim, significantly limiting fertilization capabilities," said lead investigator Michael O'Rand. "This makes EP055 an ideal candidate for non-hormonal male contraception."
Currently, condoms and surgical vasectomy are the only safe forms of birth control currently available for men. There are hormonal drugs in clinical trials that target the production of sperm, but these affect the natural hormones in men much like female contraceptives affect hormones in women.
During the study, thirty hours following a high-dose intravenous infusion of EP055 in male rhesus macaques, O'Rand and researchers found no indication of normal sperm motility. Further, no physical side effects were observed.
"At 18 days post-infusion, all macaques showed signs of complete recovery, suggesting that the EP055 compound is indeed reversible," said study co-investigator Mary Zelinski.
O'Rand and Zelinski indicate that more work is needed before EP055 becomes available for human use. They and their teams have begun to test a pill form of the compound and will eventually conduct a mating trial of EP055's effectiveness against pregnancy.
The study appears in the journal PLOS ONE.
© 2024 Hyderabad Media House Limited/The Hans India. All rights reserved. Powered by hocalwire.com